PSMA-RLT in Biochemically Recurrent PCa — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PSMA-RLT in Biochemically Recurrent PCa — Stella

Recruiting

Back to Prostate Cancer Recurrent trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Austria

Medical University of Vienna, Vienna

Key details

Phase

Safety & dosing

Sponsor

Medical University of Vienna

Enrollment target

~20 participants

Started

January 2024

Primary completion

June 2026

Age range

18 Years – 80 Years

Sex

Male only

Last updated February 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov